Cargando…
Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon
Obesity is a prevalent global health issue affecting approximately half of the world’s population. Extensive scientific research highlights the urgent need for effective obesity management to mitigate health risks and prevent complications. While bariatric surgery has proven to be highly effective,...
Autores principales: | Jeon, Eonju, Lee, Ki Young, Kim, Kyoung-Kon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for the Study of Obesity
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10327684/ https://www.ncbi.nlm.nih.gov/pubmed/37349257 http://dx.doi.org/10.7570/jomes23032 |
Ejemplares similares
-
Understanding the Mechanism of Action and Clinical Implications of Anti-Obesity Drugs Recently Approved in Korea
por: Kim, Kyoung Kon
Publicado: (2019) -
Diagnosis of Obesity: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
por: Haam, Ji-Hee, et al.
Publicado: (2023) -
Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
por: Kim, Kyoung-Kon, et al.
Publicado: (2023) -
A narrative review of approved and emerging anti-obesity medications
por: Abdi Beshir, Semira, et al.
Publicado: (2023) -
The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits
por: Hinney, Anke, et al.
Publicado: (2022)